- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HEC-Glargine
Total 1908 results
-
Skane University HospitalMedical Research Council; Skane County Council Research & Development FoundationCompletedType 2 Diabetes | Secondary Drug FailureSweden
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Mylan Inc.Mylan GmbHCompletedType 2 DiabetesUnited States, Jordan, Korea, Republic of, Slovakia, South Africa, Taiwan
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1 | Healthy VolunteersUnited States
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
Universidad Nacional de AsunciónCompletedHyperglycemia | DiabetesParaguay
-
University of AarhusCompletedDiabetes Mellitus, Type 1Denmark
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Australia, Spain, Korea, Republic of, Hungary, Mexico, Italy, Poland, Argentina, Canada, Colombia, France, Germany, Japan, Peru, Romania, Sweden, United Kingdom
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1United States
-
SanofiCompleted
-
SanofiCompletedType I Diabetes MellitusBrazil
-
Shenzhen Second People's HospitalUnknown
-
Novo Nordisk A/SCompleted
-
Mira ZuidgeestSanofi; Innovative Medicines Initiative; IMI Trials@Home consortiumRecruitingDiabetes Mellitus, Type 2United Kingdom, Denmark, Germany
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Korea, Republic of, Russian Federation
-
SanofiCompletedType 2 Diabetes MellitusUnited States
-
BiodelCompletedDiabetes MellitusUnited States
-
Merck Sharp & Dohme LLCCompleted
-
SanofiActive, not recruiting
-
SanofiCompleted
-
SanofiCompleted
-
SanofiCompletedType 1 Diabetes MellitusFrance, Czechia, Chile, Israel, Spain, Hungary, Mexico, Serbia, Japan, Canada, Brazil, Sweden, Denmark, Argentina, United States, Bulgaria, Germany, Italy, Latvia, North Macedonia, Poland, Romania, Russian Federation, United Kingdom
-
SanofiCompleted
-
Medical University of GrazCompletedDiabetes Mellitus, Type 2Austria
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA)CompletedHIV Infections | Hepatitis, Viral, HumanUnited States
-
Emory UniversityMerck Sharp & Dohme LLC; University of Michigan; Temple University; Ohio UniversityCompleted
-
Medical University of ViennaCompletedType 2 Diabetes MellitusAustria
-
SanofiCompleted
-
University of PadovaCompletedCardiovascular Disease | Type 2 Diabetes | Endothelial DysfunctionItaly
-
Munich Municipal HospitalAventis PharmaceuticalsUnknownCoronary Artery Disease | Type 2 DiabetesGermany
-
SanofiTerminated
-
Hunan Province Tumor HospitalCompletedExtensive Stage Small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Emory UniversityNovo Nordisk A/SCompleted
-
Gan and Lee Pharmaceuticals, USACompletedDiabetes Mellitus, Type 1Spain, United States, Germany, Czechia, Hungary, Poland
-
SanofiCompletedDiabetesPeru, Ukraine, Colombia, Egypt, India, Indonesia, Israel, Jordan, Kuwait, Lebanon, Mexico, Philippines, Russian Federation, Saudi Arabia, Singapore, Taiwan, Thailand, United Arab Emirates
-
Emory UniversityCompletedPoor Glycemic ControlUnited States
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Canada, Denmark, Hungary, Serbia, Germany, Greece, Romania, Estonia, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, Canada, United Kingdom, Ireland, France, South Africa, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Netherlands, Hungary, France, Bulgaria, Canada, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
Merck Sharp & Dohme LLCTerminated
-
SanofiCompletedType 2 Diabetes MellitusGermany, United Kingdom